Summary of Afatinib side effects and treatment options

Afatinib is a targeted drug used to treat epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer. Although afatinib can significantly improve the prognosis of patients with EGFR mutation-positive non-small cell lung cancer, it may also cause certain side effects. Understanding these side effects and how to manage them is critical for patients and health care providers. The following is a summary of common side effects of afatinib and treatment options.

1. Skin-related side effects

Skin problems are one of the most common side effects of afatinib treatment. Patients may experience rash, itching, dryness, redness and swelling. Particularly on the face, back and chest areas, these skin reactions usually appear within the first two weeks of treatment. The occurrence of rash may affect the patient's quality of life and therefore requires prompt treatment.

Solution:

Mild rashes are usually relieved by topical application of moisturizers or hormonal ointments. Severe rashes may need to be treated with oral antihistamines or topical antibiotics.

If the rash is accompanied by severe inflammation or signs of infection, afatinib treatment may need to be suspended and a more potent treatment regimen, such as oral antibiotics, directed by a physician.

Severe skin reactions require modification of treatment regimen and may require suspension or reduction of medication dose, depending on the severity of symptoms.

2. Oral and gastrointestinal reactions

Afatinib may also cause oral and gastrointestinal discomfort, such as oral ulcers, dry mouth, loss of appetite, nausea, vomiting, diarrhea and other symptoms. Oral ulcers often appear in the early stages of treatment and may affect the patient's eating and quality of life. Diarrhea is also a common side effect of afatinib and may cause fluid and electrolyte loss, posing additional health risks to patients.

Solution:

Oral ulcers can be relieved by using gargles or local anesthetics, and patients should keep their mouths clean and avoid spicy and irritating foods.

For nausea and vomiting, doctors usually recommend antiemetic drugs, such as ondansetron (Ondansetron), based on the patient’s symptoms.

Patients with diarrhea can take anti-diarrheal drugs, such as loperamide (Loperamide). If the diarrhea is severe, medication may need to be suspended and fluids and electrolytes replenished.

If diarrhea persists or worsens, your doctor may consider adjusting the medication dose or switching to a different medication regimen.

3. Lung problems

Although afatinib has significant efficacy in patients with non-small cell lung cancer, some patients may experience lung-related side effects during treatment, such as interstitial lung disease (ILD) or pneumonia. These reactions are often serious and require prompt monitoring and treatment. Patients should be alert if they experience symptoms such as shortness of breath, persistent cough, or chest pain.

Solution:

Early diagnosis and timely treatment are key to preventing lung problems from getting worse. Patients who develop dyspnea should immediately stop taking the drug and have imaging studies (such as chest CT scans) to evaluate the condition of their lungs.

If interstitial lung disease or pneumonia is diagnosed, patients may need to receive steroid therapy (such as prednisone) or other immunosuppressive treatments.

Severe pulmonary reactions may require discontinuation of afatinib therapy and the selection of an alternative treatment option as recommended by your physician.

4. Cardiovascular side effects

During afatinib treatment, patients may also experience cardiovascular side effects, such as high blood pressure and cardiac discomfort. By inhibiting the activity of EGFR and other targets, afatinib may affect the normal function of blood vessels and lead to an increase in blood pressure. Although these side effects are less common, they are still a cause for concern.

Solution:

Monitor blood pressure regularly, especially during the initial stages of afatinib treatment. If a patient develops high blood pressure, the doctor may recommend antihypertensive medications to control blood pressure.

If cardiovascular symptoms are obvious or persistent, it may be necessary to adjust the treatment plan, consider using other medications for management, or suspend treatment under the guidance of a physician.

Patients should pay attention to factors such as diet and living habits during treatment, and try to avoid factors that may cause high blood pressure.

Although afatinib has achieved significant efficacy in the treatment of non-small cell lung cancer, its side effects cannot be ignored. Skin problems, oral and gastrointestinal reactions, pulmonary problems, and cardiovascular side effects are the most common side effects, so patients should pay close attention to these possible reactions while using afatinib. Communicate with the doctor in a timely manner, follow the doctor's instructions, and adjust the treatment plan, which can effectively alleviate side effects and ensure the continuity and efficacy of treatment. In addition, patients should receive regular examinations during treatment to detect and deal with any adverse reactions as early as possible, thereby improving the safety and effectiveness of treatment.

References：https://www.giotrif.com/